Por favor, use este identificador para citar o enlazar a este item:
http://hdl.handle.net/10261/176988
COMPARTIR / EXPORTAR:
SHARE CORE BASE | |
Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL | DATACITE | |
Título: | Overexpression of TFEB drives a pleiotropic neurotrophic effect and prevents parkinson's disease-related neurodegeneration |
Autor: | Torra, Alber; Parent, Annabelle; Cuadros, Thais; Rodríguez-Galván, Beatriz; Ruiz-Bronchal, Esther CSIC ORCID; Ballabio, Andrea; Bortolozzi, Analía CSIC ORCID; Vila, Miquel; Bové, Jordi | Palabras clave: | TFEB Neurotrophic Parkinson's disease Neuroprotection Neurorescue Dopamine MPTP Neuronal atrophy Prosurvival pathways |
Fecha de publicación: | 6-jun-2018 | Editor: | Elsevier | Citación: | Molecular Therapy 26(6): 1552-1567 (2018) | Resumen: | The possible implication of transcription factor EB (TFEB) as a therapeutic target in Parkinson’s disease has gained momentum since it was discovered that TFEB controls lysosomal biogenesis and autophagy and that its activation might counteract lysosomal impairment and protein aggregation. However, the majority of putative direct targets of TFEB described to date is linked to a range of biological processes that are not related to the lysosomal-autophagic system. Here, we assessed the effect of overexpressing TFEB with an adeno-associated viral vector in mouse substantia nigra dopaminergic neurons. We demonstrate that TFEB overexpression drives a previously unknown bona fide neurotrophic effect, giving rise to cell growth, higher tyrosine hydroxylase levels, and increased dopamine release in the striatum. TFEB overexpression induces the activation of the mitogen-activated protein kinase 1/3 (MAPK1/3) and AKT pro-survival pathways, phosphorylation of mTORC1 effectors 4E-binding protein 1 (4E-BP1) and S6 kinase B1 (S6K1), and increased protein synthesis. We show that TFEB overexpression prevents dopaminergic cell loss and counteracts atrophy and the associated protein synthesis decline in the MPTP mouse model of Parkinson’s disease. Our results suggest that increasing TFEB activity might prevent neuronal death and restore neuronal function in Parkinson’s disease and other neurodegenerative diseases through different mechanisms. | Versión del editor: | https://doi.org/10.1016/j.ymthe.2018.02.022 | URI: | http://hdl.handle.net/10261/176988 | DOI: | 10.1016/j.ymthe.2018.02.022 | ISSN: | 1525-0016 | E-ISSN: | 1525-0024 |
Aparece en las colecciones: | (IIBB) Artículos |
Ficheros en este ítem:
Fichero | Descripción | Tamaño | Formato | |
---|---|---|---|---|
accesoRestringido.pdf | 15,38 kB | Adobe PDF | Visualizar/Abrir |
CORE Recommender
PubMed Central
Citations
36
checked on 28-mar-2024
SCOPUSTM
Citations
55
checked on 15-abr-2024
WEB OF SCIENCETM
Citations
49
checked on 27-feb-2024
Page view(s)
211
checked on 19-abr-2024
Download(s)
17
checked on 19-abr-2024
Google ScholarTM
Check
Altmetric
Altmetric
Artículos relacionados:
NOTA: Los ítems de Digital.CSIC están protegidos por copyright, con todos los derechos reservados, a menos que se indique lo contrario.